Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells

Stem Cell Reviews and Reports

Volumn 6, Issue 2, 2010, Pages 248-259

  Amit, Michal ^a   Chebath, Judith ^b   Margulets, Victoria ^a   Laevsky, Ilana ^a   Miropolsky, Yael ^a   Shariki, Kohava ^a   Peri, Meital ^a   Blais, Idit ^a   Slutsky, Guy ^b   Revel, Michel ^b   Itskovitz Eldor, Joseph ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

3D; Bioreactor; Embryonic stem cells; Gp130; IL6 IL6 receptor chimera; Induced pluripotent stem cells; Suspension

Indexed keywords

HYBRID PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENETICS; HUMAN; KARYOTYPING; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DRUG EFFECTS;

APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INTERLEUKIN-6; KARYOTYPING; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS;

EID: 77953913401     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9149-y     Document Type: Article

References (38)

1. Thomson, J. A., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147.
2. Amit, M., et al. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Developmental Biology, 227, 271-278.
3. Ludwig, T. E., et al. (2006). Derivation of human embryonic stem cells in defined conditions. Nature Biotechnology, 24, 185-187.
4. Xu, C., Inokuma, M. S., Denham, J., et al. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnology, 19, 971-974.
5. Amit, M., et al. (2004). Feeder and serum-free culture system for human embryonic stem cells. Biology of Reproduction, 70, 837-845.
6. Xu, C., et al. (2005). Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells, 23, 315-323.
7. Xu, R. H., et al. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nature Methods, 2, 185-190.
8. Richards, M., et al. (2002). Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nature Biotechnology, 20, 933-936.
9. Amit, M., et al. (2003). Human feeder layers for human embryonic stem cells. Biology of Reproduction, 68, 2150-2156.
10. Hovatta, O., et al. (2003). Culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Human Reproduction, 18, 1404-1409.
11. Cheng, L., et al. (2003). Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells, 21, 131-142.
12. Smith, A. G., et al. (1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature, 336, 688-690.
13. Williams, R. L., et al. (1988). Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature, 336, 684-687.
14. Rose, T. M., et al. (1994). Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. Cytokine, 6, 48-54.
15. Conover, J. C., et al. (1993). Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development, 119, 559-565.
16. Niwa, H., et al. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes and Development, 12, 2048-2060.
17. Reubinoff, B. E., et al. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnology, 18, 399-404.
18. Daheron, L., et al. (2004). LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells, 22, 770-778.
19. Sato, N., et al. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Medicine, 10, 55-63.
20. Humphrey, R. K., et al. (2004). Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells, 22, 522-530.
21. Taga, T., & Kishimoto, T. (1997). Gp130 and the interleukin-6 family of cytokines. Annual Review of Immunology, 15, 797-819.
22. Novick, D., et al. (1992). Enhancement of interleukin-6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine, 4, 6-11.
23. Chebath, J., et al. (1997). Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities. European Cytokine Network, 8, 359-365.
24. -/low cells capable of repopulating Severe Combined Immunodeficiency mice. Blood, 94, 923-931.
25. Itskovitz-Eldor, J., et al. (2000). Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Molecular Medicine, 6, 88-95.
26. Thomson, J. A., et al. (1995). Isolation of a primate embryonic stem cell line. Proceedings of the National Academy of Sciences of the United States of America, 92, 7844-7848.
27. Thomson, J. A., et al. (1995). Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biology of Reproduction, 55, 254-259.
28. Yoshida, K., et al. (1994). Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mechanisms of Development, 45, 163-171.
29. Shen, M. M., & Leder, P. (1992). Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci U S A, 89(17), 8240-8244.
30. Rodriguez, R. T., et al. (2007). Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types. Experimental Biology and Medicine, 232, 1368-1380.
31. Beattie, G. M., et al. (2005). Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells, 23, 489-495.
32. Wang, L., et al. (2005). Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood, 105, 4598-4603.
33. Cormier, J. T., et al. (2006). Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors. Tissue Engineering, 12, 3233-3245.
34. Zur Nieden, N. I., et al. (2007). Embryonic stem cells remain highly pluripotent following long term expansion as aggregates in suspension bioreactors. Journal of Biotechnology, 129, 421-432.
35. Phillips, B. W., et al. (2008). Attachment and growth of human embryonic stem cells on microcarriers. Journal of Biotechnology, 138, 24-32.
36. Oh, S. K., et al. (2009). Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cells Research. Mar 4. [Epub ahead of print].
37. Krawetz, R., et al. (2009). Large-Scale Expansion of Pluripotent Human Embryonic Stem Cells in Stirred Suspension Bioreactors. Tissue Eng Part C Methods. Sep 8. [Epub ahead of print].
38. Amit, M., & Itskovitz-Eldor, J. (2002). Derivation and spontaneous differentiation of human embryonic stem cells. Journal of Anatomy, 200, 225-232.